Sur vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Sur
82.0%
in 2024
Togo
100.0%
in 2024
Sur rank
2nd
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sur
- Togo
How they compare
Togo currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Togo's figure about 1.2 times Sur's.
The two have swapped places 1 time across 17 shared years of data; in 2008 it was Sur ahead.
Sur ranks 2nd and Togo ranks 1st of 2 regions.
Across the 3 decades both report, Sur averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Sur | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.0% | 33.0% | 8.0% | Sur |
| 2010s | 66.3% | 85.1% | 18.8% | Togo |
| 2020s | 75.8% | 99.2% | 23.4% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sur or Togo?
- Togo, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sur and Togo?
- 18.0%, with Togo ahead.
- How many years of comparable data are there for Sur and Togo?
- 17 years are reported by both, from 2008 to 2024.
- How do Sur and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd and Togo ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.